Article Text
Papers
18F-Fluoro-2-deoxyglucose positron emission tomography in the evaluation of gastrointestinal malignancies
Abstract
Positron emission tomography with 18F-fluoro-2-deoxyglucose is an imaging technology that is demonstrating increasing utility in the evaluation of gastrointestinal malignancies.
- positron emission tomography
- 18F-Fluoro-2-deoxyglucose
- PET, positron emission tomography
- FDG, 18F-fluoro-2-deoxyglucose
- CT, computed tomography
- CEA, carcinoembryonic antigen
Statistics from Altmetric.com
Footnotes
-
Conflicts of interest: RLW has research agreement with GE Medical Systems and Siemens Medical Systems. RLW has received honorariums from GE Medical Systems, Siemens Medical Systems, Phillips, and Mobile Pet Systems. RLW is a stockholder in CTI-MI.